Persisting Ductus Arteriosus and Respiratory Problems

  • Walter Kachel


Premature Infant Respiratory Distress Syndrome Patent Ductus Arteriosus Chronic Lung Disease Pulmonary Hemorrhage 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Evans N, Iyer P. Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: Correlation with respiratory outcomes. Arch Dis Child Fetal Neonatal Ed. 1995; 72: F156–61.PubMedCrossRefGoogle Scholar
  2. Van de Bor M, Verloove-Vanhorick SP, Brand R, Ruys JH. Patent ductus arteriosus in a cohort of 1338 preterm infants: a collaborative study. Paediatr Perinat Epidemiol. 1988; 2: 328–36.PubMedCrossRefGoogle Scholar
  3. Koyama N, Ogawa Y, Kamiya K, et al: Increased platelet activating factor in the tracheal aspirates from neonates with patent ductus arteriosus. Clin Chim Acta 1993; 215: 73–9.CrossRefPubMedGoogle Scholar
  4. Nakamura T, Takasaki J, Ogawa Y. Inflammatory changes in the lungs of premature infants with symptomatic patent ductus arteriosus. Pediatrics International 2002; 44: 363–7.PubMedCrossRefGoogle Scholar
  5. Varsila E, Hallman M, Venge P, Andersson S. Closure of patent ductus arteriosus decreases pulmonary myeloperoxidase in premature infants with respiratory distress syndrome. Biol Neonat 1995; 67: 167–71.Google Scholar
  6. Hutchison AA, Ogletree ML, Palme CJ, Leheup BP, Barrett JM, Fleischer AC, Stahlman MT, Brigham KL. Plasma 6-keto prostaglandin F1 alpha and thromboxane B2 in sick preterm neonates. Prostaglandins Leukot Med. 1985; 18: 163–81.CrossRefPubMedGoogle Scholar
  7. Kluckow M, Evans N, Leslie G, Rowe J. Prostacyclin concentrations and transitional circulation in preterm infants requiring mechanical ventilation. Arch Dis Child Fetal Neonatal Ed. 1999; 80: F34–7.PubMedCrossRefGoogle Scholar
  8. Odita JC. The significance of recurrent lung opacities in neonates on surfactant treatment for respiratory distress syndrome. Pediatr Radiol. 2001; 31: 87–91.CrossRefPubMedGoogle Scholar
  9. Alpan G, Scheerer R, Bland R, Clyman R. Patent ductus arteriosus increases lung fluid filtration in preterm lambs. Pediatr Res. 1991; 30: 616–21.PubMedCrossRefGoogle Scholar
  10. Alpan G, Mauray F, Clyman RI. Effect of patent ductus arteriosus on water accumulation and protein permeability in the lungs of mechanically ventilated premature lambs. Pediatr Res. 1989; 26: 570–5.PubMedCrossRefGoogle Scholar
  11. Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr 2000; 137: 68–72.CrossRefPubMedGoogle Scholar
  12. Naulty CM, Horn S, Conry J, Avery GB. Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane disease. J Pediatr 1978; 93: 682–4PubMedCrossRefGoogle Scholar
  13. Gerhardt T, Bancalari E. Lung compliance in newborns with patent ductus arteriosus before and after surgical ligation. Biol Neonate 1980; 38: 96–105.PubMedCrossRefGoogle Scholar
  14. Yeh TF, Thalji A, Luken L, Lilien L, Carr I, Pildes RS. Improved lung compliance following indomethacin therapy in premature infants with persistent ductus arteriosus. Chest 1981; 80: 698–700.PubMedCrossRefGoogle Scholar
  15. Balsan MJ, Jones JG, Guthrie RD. Effects of a clinically detectable PDA on pulmonary mechanics measures in VLBW infants with RDS. Pediatr Pulmonol 1991; 11: 161–5.PubMedCrossRefGoogle Scholar
  16. Krauss AN, Fatica N, Lewis BS, Cooper R, Thaler HT, Cirrincione C, O’Loughlin J, Levin A, Engle MA, Auld PA. Pulmonary function in preterm infants following treatment with intravenous indomethacin. Am J Dis Child 1989; 143: 78–81.PubMedGoogle Scholar
  17. Farstad T, Bratlid D. Pulmonary effects of closure of patent ductus arteriosus in premature infants with severe respiratory distress syndrome. Eur J Pediatr 1994; 153: 903–5.PubMedCrossRefGoogle Scholar
  18. Szymankiewicz M, Hodgman JE, Siassi B, Gadzinowski J. Mechanics of breathing after surgical ligation of patent ductus arteriosus in newborns with respiratory distress syndrome. Biol Neonat 2004; 85: 32–6.CrossRefGoogle Scholar
  19. Heldt GP, Pesonen E, Merritt TA, Elias W, Sahn DJ. Closure of the ductus arteriosus and mechanics of breathing in preterm infants after surfactant replacement therapy. Pediatr Res 1989; 25: 305–10.PubMedCrossRefGoogle Scholar
  20. Reller MD, Buffkin DC, Colasurdo MA, Rice MJ, McDonald RW. Ductal patency in neonates with respiratory distress syndrome. Am J Dis Child 1991; 145: 1017–20.PubMedGoogle Scholar
  21. Peckham GJ, Miettinen OS, Ellison RC, Kraybill EN, Gersony WM, Zierler S, Nadas AS. Clinical course to 1 year of age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin. J Pediatr 1984; 105: 285–91.PubMedCrossRefGoogle Scholar
  22. Malviya M, Ohlsson A, Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2003;(3):CD003951.Google Scholar
  23. Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2003;(2): CD004213.Google Scholar
  24. Cooke L, Steer P, Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2003; (2): CD003745.Google Scholar
  25. Herrera C, Holberton J, Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2004;(1):CD003480.Google Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2005

Authors and Affiliations

  • Walter Kachel
    • 1
  1. 1.Department of Pediatrics/PerinatalzentrumSLK-Kliniken Heilbronn GmbHHeilbronn

Personalised recommendations